May 2 |
Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
|
May 2 |
Q1 2024 Corcept Therapeutics Inc Earnings Call
|
May 2 |
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
|
Apr 30 |
Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
|
Apr 30 |
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
|
Apr 22 |
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
|
Apr 22 |
UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
Apr 21 |
11 Best Low Price Pharma Stocks To Invest In
|
Apr 19 |
Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
|
Apr 19 |
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
|